Literature DB >> 21505266

Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia.

Tetsuya Tagami1, Hironori Kimura, Sumire Ohtani, Tsuyoshi Tanaka, Takashi Tanaka, Shiro Hata, Miho Saito, Yasushi Miyazaki, Rika Araki, Masami Tanaka, Kazuya Yonezawa, Morio Sawamura, Takuyuki Ise, Atsushi Ogo, Takuro Shimbo, Akira Shimatsu, Mitsuhide Naruse.   

Abstract

Hypercholesterolemia is one of the most representative disorders of the common diseases. To evaluate the prevalence of hypothyroidism in the population of adult hypercholesterolemia, we prospectively examined the thyroid function in patients with untreated or treated hypercholesterolemia as a multi-center survey. Subjects were the patients who were treated with some antilipemic agents or the untreated patients whose total cholesterol (TC) was over 220 mg/dL and/or LDL-cholesterol (LDL-C) over 140 mg/dL. Among 737 cases recruited, 725 cases (300 males and 425 females) participated in the survey including the thyroid function test. The patient's backgrounds include hypertension (51%), diabetes mellitus (49%), fatty liver (17%), smoking (15%), and habitual drinking (10%). The 72% of the patients were treated with some antilipemic agents and the mean values of TC, LDL-C, triglyceride (TG), HDL-cholesterol (HDL-C), and LDL-C/HDL-C ratio (L/H) were 204.5 mg/dL, 119.6 mg/dL, 144.4 mg/dL, 60.7 mg/dL and 2.25, respectively. The primary hypothyroidism was seen in 27 cases (3.7%) (11 males, 16 females) with subclinical hypothyroidism in 17 cases (2.4%) and overt hypothyroidism in 10 cases (1.4%). The central hypothyroidism was seen in 4 cases (0.6%). The prevalence of hypothyroidism was 4.3% in patients with hypercholesterolemia. Taking account of the large number of patients with dyslipidemia and importance of avoiding unnecessary administration and associated adverse effects, evaluation of the thyroid function could be warranted in patients with dyslipidemia although cost-benefit issues waits further investigation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505266     DOI: 10.1507/endocrj.k11e-012

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  10 in total

Review 1.  Diagnosis and treatment of hypothyroidism in the elderly.

Authors:  Leonidas H Duntas; Paul Michael Yen
Journal:  Endocrine       Date:  2019-09-03       Impact factor: 3.633

2.  Thyroid function testing in patients with newly diagnosed hyperlipidemia.

Authors:  Devina L Willard; Angela M Leung; Elizabeth N Pearce
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

3.  Central hypothyroidism in adults: better understanding for better care.

Authors:  Solange Grunenwald; Philippe Caron
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

4.  Thyroid dysfunction in an adult female population: A population-based study of Latin American Vertebral Osteoporosis Study (LAVOS) - Puerto Rico site.

Authors:  Loida A González-Rodríguez; Marcos E Felici-Giovanini; Lillian Haddock
Journal:  P R Health Sci J       Date:  2013-06       Impact factor: 0.705

5.  Free Triiodothyronine and Cholesterol Levels in Euthyroid Elderly T2DM Patients.

Authors:  F Strollo; I Carucci; M Morè; G Marico; G Strollo; M A Masini; S Gentile
Journal:  Int J Endocrinol       Date:  2012-09-03       Impact factor: 3.257

6.  Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years.

Authors:  Ulla Ludwig; Daniela Holzner; Christian Denzer; Artur Greinert; Mark Martin Haenle; Suemeyra Oeztuerk; Wolfgang Koenig; Bernhard Otto Boehm; Richard Andrew Mason; Wolfgang Kratzer; Tilmann Graeter
Journal:  BMC Endocr Disord       Date:  2015-08-15       Impact factor: 2.763

Review 7.  A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism.

Authors:  Leonidas H Duntas; Gabriela Brenta
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-03       Impact factor: 5.555

Review 8.  Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism.

Authors:  Huixing Liu; Daoquan Peng
Journal:  Endocr Connect       Date:  2022-02-07       Impact factor: 3.335

9.  The Relationship of Circulating Proprotein Convertase Subtilisin/Kexin Type 9 With TSH and Lipid Profile in Newly Diagnosed Patients With Subclinical and Overt Hypothyroidism.

Authors:  Noha Adly Sadik; Laila Ahmed Rashed; Shereen Sadik El-Sawy
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2022-04-21

Review 10.  Levothyroxine for the Treatment of Subclinical Hypothyroidism and Cardiovascular Disease.

Authors:  Laura Y Sue; Angela M Leung
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-21       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.